Development of a machine learning model to predict risk of development of COVID-19-associated mucormycosis

被引:1
|
作者
Patil, Rajashri [1 ]
Mukhida, Sahjid [1 ]
Ajagunde, Jyoti [1 ]
Khan, Uzair [1 ]
Khan, Sameena [1 ]
Gandham, Nageswari [1 ]
Vyawhare, Chanda [1 ]
Das, Nikunja K. [1 ]
Mirza, Shahzad [1 ]
机构
[1] Dr DY Patil Vidyapeeth, Dr DY Patil Med Coll Hosp & Res Ctr, Dept Microbiol, Pune 18, India
关键词
COVID-19-associated mucormycosis; machine learning; mucormycosis; rhino-orbito-cerebral mucormycosis;
D O I
10.2217/fmb-2023-0190
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Aim: The study aimed to identify quantitative parameters that increase the risk of rhino-orbito-cerebral mucormycosis, and subsequently developed a machine learning model that can anticipate susceptibility to developing this condition. Methods: Clinicopathological data from 124 patients were used to quantify their association with COVID-19-associated mucormycosis (CAM) and subsequently develop a machine learning model to predict its likelihood. Results: Diabetes mellitus, noninvasive ventilation and hypertension were found to have statistically significant associations with radiologically confirmed CAM cases. Conclusion: Machine learning models can be used to accurately predict the likelihood of development of CAM, and this methodology can be used in creating prediction algorithms of a wide variety of infections and complications. Fungal infections caused by the Mucorales order of fungi usually target patients with a weakened immune system. They are usually also associated with abnormal blood sugar states, such as in diabetic patients. Recent work during the COVID-19 outbreak suggested that excessive steroid use and diabetes may be behind the rise in fungal infections caused by Mucorales, known as mucormycosis, in India, but little work has been done to see whether we can predict the risk of mucormycosis. This study found that these fungal infections need not necessarily be caused by Mucorales species, but by a wide variety of fungi that target patients with weak immune systems. Secondly, we found that diabetes, breathing-assisting devices and high blood pressure states had associations with COVID-19-associated fungal infections. Finally, we were able to develop a machine learning model that showed high accuracy when predicting the risk of development of these fungal infections.
引用
收藏
页码:297 / 305
页数:9
相关论文
共 50 条
  • [1] Development of a Machine Learning Model to Predict Risk of Development of COVID-19-Associated Mucormycosis (vol 19, pg 297, 2024)
    Patil, R.
    Mukhida, S.
    Ajagunde, J.
    FUTURE MICROBIOLOGY, 2024, 19 (18) : 1619 - 1619
  • [2] A Study on Enumeration of Factors Prone to the Development of COVID-19-Associated Mucormycosis
    Velusamy, Sivakumar
    Rajagopal, Jayakumar
    Jayakumar, Jessica
    Parthiban, Dharshini
    Hussain, Adeeb Ismail Zahir
    JOURNAL OF HEALTH AND ALLIED SCIENCES NU, 2024, 14 (02): : 224 - 229
  • [3] COVID-19-associated mucormycosis and treatments
    Subramaniyan, Vetriselvan
    Fuloria, Shivkanya
    Darnal, Hari Kumar
    Meenakshi, Dhanalekshmi Unnikrishnan
    Sekar, Mahendran
    Bin Nordin, Rusli
    Chakravarthi, Srikumar
    Sathasivam, Kathiresan V.
    Khan, Shah Alam
    Wu, Yuan Seng
    Kumari, Usha
    Sudhakar, Kalvatala
    Malviya, Rishabha
    Sharma, Vipin Kumar
    Fuloria, Neeraj Kumar
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2021, 14 (09) : 401 - 409
  • [4] COVID-19-associated mucormycosis and treatments
    Vetriselvan Subramaniyan
    Shivkanya Fuloria
    Hari Kumar Darnal
    Dhanalekshmi Unnikrishnan Meenakshi
    Mahendran Sekar
    Rusli Bin Nordin
    Srikumar Chakravarthi
    Kathiresan V.Sathasivam
    Shah Alam Khan
    Yuan Seng Wu
    Usha Kumari
    Kalvatala Sudhakar
    Rishabha Malviya
    Vipin Kumar Sharma
    Neeraj Kumar Fuloria
    Asian Pacific Journal of Tropical Medicine, 2021, 14 (09) : 401 - 409
  • [5] COVID-19-Associated Pulmonary Mucormycosis
    Krishna, Vidya
    Bansal, Nitin
    Morjaria, Jaymin
    Kaul, Sundeep
    JOURNAL OF FUNGI, 2022, 8 (07)
  • [6] Epidemiology of COVID-19-Associated Mucormycosis
    Tayabali, Khadija
    Pothiwalla, Hussein
    Narayanan, Shivakumar
    CURRENT FUNGAL INFECTION REPORTS, 2023, 17 (02) : 156 - 175
  • [7] Development and validation of a machine learning model to predict mortality risk in patients with COVID-19
    Stachel, Anna
    Daniel, Kwesi
    Ding, Dan
    Francois, Fritz
    Phillips, Michael
    Lighter, Jennifer
    BMJ HEALTH & CARE INFORMATICS, 2021, 28 (01)
  • [8] Rhinocerebral mucormycosis: A clinicopathological analysis of COVID-19-associated mucormycosis
    Bahal, Neelima
    Piyush, A. R.
    Kala, Pooja Sharma
    Dogra, Shruti
    Thapliyal, Naveen
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (08) : 3257 - 3263
  • [9] Prevention and Treatment of COVID-19-Associated Mucormycosis
    Kevin T. Grafmiller
    Jivianne T. Lee
    Current Treatment Options in Allergy, 2023, 10 : 83 - 92
  • [10] Prevention and Treatment of COVID-19-Associated Mucormycosis
    Grafmiller, Kevin T.
    Lee, Jivianne T.
    CURRENT TREATMENT OPTIONS IN ALLERGY, 2023, 10 (02) : 83 - 92